Independent
Tenure on this board
5.3 yrs
Also a director at
Bloomin' Brands Inc (BLMN)
Meeting calendar
WOOF · Annual meeting · Thursday, July 24, 2025
Petco Health & Wellness Company Inc
3 nominees · 3 ballot items.
Election of three Class II directors; advisory Say-on-Pay vote on named executive officer compensation; and ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for the 2026 fiscal year.
Market cap
$880M
1Y TSR
-5.3%
Board grade
C-
Record date
May 27, 2025
Filing
DEF 14A
Meeting concluded · Jul 24, 2025
Follow how the vote landed and what changed on Petco Health & Wellness Company Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Class II Directors
ManagementBoard: FORElection of three Class II directors to serve three-year terms on the board.
- 2
Non-Binding Say-On-Pay Vote to Approve Named Executive Officer Compensation
ManagementBoard: FORAdvisory vote to approve the compensation of the company’s named executive officers for the fiscal year ended February 1, 2025.
- 3
Ratification of Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm
ManagementBoard: FORRatification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending January 31, 2026.
Director elections
Nominees on the ballot3
Not independent
Tenure on this board
3.0 yrs
Not independent
Tenure on this board
5.5 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | CVC Management Holdings II Ltd. | 45.1% | 145,924,140 | $406M |
| 2 | CANADA PENSION PLAN INVESTMENT BOARD | 18.5% | 59,765,368 | $166M |
| 3 | DIMENSIONAL FUND ADVISORS LP | 3.0% | 9,661,605 | $27M |
| 4 | Long Focus Capital Management, LLC | 2.5% | 8,010,051 | $22M |
| 5 | TWO SIGMA INVESTMENTS, LP | 1.8% | 5,969,574 | $17M |
| 6 | Holocene Advisors, LP | 1.8% | 5,762,654 | $16M |
| 7 | FMR LLC | 1.3% | 4,138,605 | $12M |
| 8 | Cresset Asset Management, LLC | 1.2% | 3,865,368 | $11M |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 1.1% | 3,483,352 | $10M |
| 10 | BlackRock, Inc. | 1.0% | 3,200,366 | $9M |
Peers
Nearest market capOther Consumer Cyclical sector meetings6
Upcoming shareholder meetings at Petco Health & Wellness Company Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Xmax IncXMAX
Special meeting·Jul 24, 2026·$578M
Olaplex Holdings IncOLPX
Annual meeting·Jul 9, 2026·$1.4B
Genesco IncGCO
Annual meeting·Jul 21, 2026·$375M
Capri Holdings LtdCPRI
Annual meeting·Jul 29, 2026·$2.1B
Driven Brands Holdings IncDRVN
Annual meeting·Jul 28, 2026·$2.3B
Green Brick Partners IncGRBK
Annual meeting·Jul 1, 2026·$3.5B
Reference
Frequently asked questions
- When is the Petco Health & Wellness Company Inc 2025 annual meeting?
- Petco Health & Wellness Company Inc (WOOF) holds its 2025 annual shareholder meeting on Thursday, July 24, 2025.
- What is the record date for the Petco Health & Wellness Company Inc 2025 meeting?
- The record date for the Petco Health & Wellness Company Inc 2025 meeting is Tuesday, May 27, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Petco Health & Wellness Company Inc's 2025 meeting?
- The board is presenting 3 director nominees at the Petco Health & Wellness Company Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Petco Health & Wellness Company Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Petco Health & Wellness Company Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.